BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 15795927)

  • 1. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.
    Ossipov MH; Lai J; King T; Vanderah TW; Porreca F
    Biopolymers; 2005; 80(2-3):319-24. PubMed ID: 15795927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?
    King T; Ossipov MH; Vanderah TW; Porreca F; Lai J
    Neurosignals; 2005; 14(4):194-205. PubMed ID: 16215302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance.
    Ossipov MH; Lai J; Vanderah TW; Porreca F
    Life Sci; 2003 Jun; 73(6):783-800. PubMed ID: 12801599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive and nociceptive actions of opioids.
    Ossipov MH; Lai J; King T; Vanderah TW; Malan TP; Hruby VJ; Porreca F
    J Neurobiol; 2004 Oct; 61(1):126-48. PubMed ID: 15362157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
    Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
    J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic morphine-induced loss of the facilitative interaction between vasoactive intestinal polypeptide and delta-opioid: involvement of protein kinase C and phospholipase Cbetas.
    Liu NJ; Chakrabarti S; Gintzler AR
    Brain Res; 2004 Jun; 1010(1-2):1-9. PubMed ID: 15126111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    Silverman SM
    Pain Physician; 2009; 12(3):679-84. PubMed ID: 19461836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery.
    Gardell LR; King T; Ossipov MH; Rice KC; Lai J; Vanderah TW; Porreca F
    Neurosci Lett; 2006 Mar; 396(1):44-9. PubMed ID: 16343768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ambiguities of opioid tolerance mechanisms: barriers to pain therapeutics or new pain therapeutic possibilities.
    Gintzler AR; Chakrabarti S
    J Pharmacol Exp Ther; 2008 Jun; 325(3):709-13. PubMed ID: 18354057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance.
    Vanderah TW; Suenaga NM; Ossipov MH; Malan TP; Lai J; Porreca F
    J Neurosci; 2001 Jan; 21(1):279-86. PubMed ID: 11150345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of opioid-induced hyperalgesia.
    Lee M; Silverman SM; Hansen H; Patel VB; Manchikanti L
    Pain Physician; 2011; 14(2):145-61. PubMed ID: 21412369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents.
    Stevens CW
    Cancer Surv; 1994; 21():25-47. PubMed ID: 8564997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.
    Dogrul A; Ossipov MH; Porreca F
    Brain Res; 2009 Jul; 1280():52-9. PubMed ID: 19427839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.
    Vera-Portocarrero LP; Zhang ET; King T; Ossipov MH; Vanderah TW; Lai J; Porreca F
    Pain; 2007 May; 129(1-2):35-45. PubMed ID: 17123731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions between central opioidergic and cholecystokininergic systems in rats: possible significance for the development of of opioid tolerance].
    Benoliel JJ; Becker C; Mauborgne A; Bourgoin S; Hamon M; Cesselin F
    Bull Acad Natl Med; 1998; 182(2):311-24. PubMed ID: 9648346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms.
    Wang D; Chen P; Li Q; Quirion R; Hong Y
    Behav Brain Res; 2011 Aug; 221(1):83-90. PubMed ID: 21382419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla.
    Heinricher MM; Neubert MJ
    J Neurophysiol; 2004 Oct; 92(4):1982-9. PubMed ID: 15152023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological response properties of medullary pain-control neurons following chronic treatment with morphine or oxycodone: modulation by acute ketamine.
    Viisanen H; Lilius TO; Sagalajev B; Rauhala P; Kalso E; Pertovaara A
    J Neurophysiol; 2020 Sep; 124(3):790-801. PubMed ID: 32755331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.